These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 3053176)

  • 1. Randomized controlled trial of low dose warfarin in the primary prevention of ischaemic heart disease in men at high risk: design and pilot study.
    Meade TW; Wilkes HC; Stirling Y; Brennan PJ; Kelleher C; Browne W
    Eur Heart J; 1988 Aug; 9(8):836-43. PubMed ID: 3053176
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reduction of factor VII coagulant activity (VIIC), a risk factor for ischaemic heart disease, by fixed dose warfarin: a double blind crossover study.
    Poller L; MacCallum PK; Thomson JM; Kerns W
    Br Heart J; 1990 Apr; 63(4):231-3. PubMed ID: 2186769
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Low-dose warfarin and low-dose aspirin in the primary prevention of ischemic heart disease.
    Meade TW
    Am J Cardiol; 1990 Feb; 65(6):7C-11C. PubMed ID: 2405628
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Thrombosis prevention trial: randomised trial of low-intensity oral anticoagulation with warfarin and low-dose aspirin in the primary prevention of ischaemic heart disease in men at increased risk. The Medical Research Council's General Practice Research Framework.
    Lancet; 1998 Jan; 351(9098):233-41. PubMed ID: 9457092
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antithrombotic therapy in the primary prevention of acute myocardial infarction.
    Miller GJ
    Am J Cardiol; 1989 Jul; 64(4):29B-32B. PubMed ID: 2750673
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Extra-cranial bleeding and other symptoms due to low dose aspirin and low intensity oral anticoagulation.
    Meade TW; Roderick PJ; Brennan PJ; Wilkes HC; Kelleher CC
    Thromb Haemost; 1992 Jul; 68(1):1-6. PubMed ID: 1514166
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fixed-dose versus adjusted-dose warfarin in patients with prosthetic heart valves in a peri-urban impoverished population.
    Buchanan-Leel B; Levetan BN; Lombard CJ; Commerford PJ
    J Heart Valve Dis; 2002 Jul; 11(4):583-92; discussion 593. PubMed ID: 12150309
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fiix-prothrombin time versus standard prothrombin time for monitoring of warfarin anticoagulation: a single centre, double-blind, randomised, non-inferiority trial.
    Onundarson PT; Francis CW; Indridason OS; Arnar DO; Bjornsson ES; Magnusson MK; Juliusson SJ; Jensdottir HM; Vidarsson B; Gunnarsson PS; Lund SH; Gudmundsdottir BR
    Lancet Haematol; 2015 Jun; 2(6):e231-40. PubMed ID: 26688233
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Positive association between self-reported fatty food consumption and factor VII coagulant activity, a risk factor for coronary heart disease, in 4246 middle-aged men.
    Connelly JB; Roderick PJ; Cooper JA; Meade TW; Miller GJ
    Thromb Haemost; 1993 Aug; 70(2):250-2. PubMed ID: 8236129
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pilot study of a novel patient self-management program for warfarin therapy using venipuncture-acquired international normalized ratio monitoring.
    Simmons BJ; Jenner KM; Delate T; Clark NP; Kurz D; Witt DM
    Pharmacotherapy; 2012 Dec; 32(12):1078-84. PubMed ID: 23112110
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of heart failure exacerbations on anticoagulation: a prospective, observational, pilot cohort study.
    Ripley TL; Harrison D; Germany RE; Adamson PB
    Clin Ther; 2010 Mar; 32(3):506-14. PubMed ID: 20399987
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of warfarin management with international normalized ratio self-testing and online remote monitoring and management plus low-dose vitamin k with genomic considerations: a pilot study.
    Bussey HI; Bussey M; Bussey-Smith KL; Frei CR
    Pharmacotherapy; 2013 Nov; 33(11):1136-46. PubMed ID: 24038412
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anticoagulation in women with non-valvular atrial fibrillation in the stroke prevention using an oral thrombin inhibitor (SPORTIF) trials.
    Gomberg-Maitland M; Wenger NK; Feyzi J; Lengyel M; Volgman AS; Petersen P; Frison L; Halperin JL
    Eur Heart J; 2006 Aug; 27(16):1947-53. PubMed ID: 16774980
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adjusted-dose warfarin versus low-intensity, fixed-dose warfarin plus aspirin for high-risk patients with atrial fibrillation: Stroke Prevention in Atrial Fibrillation III randomised clinical trial.
    Lancet; 1996 Sep; 348(9028):633-8. PubMed ID: 8782752
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Weight-loss induced changes in plasma factor VII coagulant activity and relation to the factor VII Arg/Gln353 polymorphism in moderately obese adults.
    Pankow JS; Folsom AR; Shahar E; Tsai MY; Jeffery RW; Wing RR
    Thromb Haemost; 1998 Apr; 79(4):784-9. PubMed ID: 9569193
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term, low-dose warfarin among venous thrombosis patients with and without factor V Leiden mutation: rationale and design for the Prevention of Recurrent Venous Thromboembolism (PREVENT) trial.
    Ridker PM
    Vasc Med; 1998; 3(1):67-73. PubMed ID: 9666536
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Moderate alcohol consumption and safety of lovastatin and warfarin among men: the post-coronary artery bypass graft trial.
    Mukamal KJ; Smith CC; Karlamangla AS; Moore AA
    Am J Med; 2006 May; 119(5):434-40. PubMed ID: 16651056
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Thrombosis prevention trial: compliance with warfarin treatment and investigation of a retained effect.
    Rudnicka AR; Ashby D; Brennan P; Meade T
    Arch Intern Med; 2003 Jun; 163(12):1454-60. PubMed ID: 12824095
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Six Months vs Extended Oral Anticoagulation After a First Episode of Pulmonary Embolism: The PADIS-PE Randomized Clinical Trial.
    Couturaud F; Sanchez O; Pernod G; Mismetti P; Jego P; Duhamel E; Provost K; dit Sollier CB; Presles E; Castellant P; Parent F; Salaun PY; Bressollette L; Nonent M; Lorillon P; Girard P; Lacut K; Guégan M; Bosson JL; Laporte S; Leroyer C; Décousus H; Meyer G; Mottier D;
    JAMA; 2015 Jul; 314(1):31-40. PubMed ID: 26151264
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A feasibility study of continuing dose-reduced warfarin for invasive procedures in patients with high thromboembolic risk.
    Larson BJ; Zumberg MS; Kitchens CS
    Chest; 2005 Mar; 127(3):922-7. PubMed ID: 15764777
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.